Search

everythinglearnresearchcommunity

for

Search:↓

Two patients treated with TAC for mouth fibrosis improved but developed Cushing's Syndrome symptoms.

Mogamulizumab, a skin cancer drug, may cause hair loss similar to alopecia areata.

Low-dose oral minoxidil helps hair regrowth in COVID-19-related hair loss with few side effects.

Corticosteroid injections for hair loss may cause eye problems, so caution is needed.

Dermatologists can accurately detect smaller differences in hair density than previously thought.

New treatments for alopecia areata show promise, but more research is needed to confirm their effectiveness.

Trichoscopy helped diagnose and cure a child's hair loss caused by a fungal infection.

Satoyoshi syndrome can cause eye problems like uveitis and retinal vein issues.

Ciclosporin A effectively treated a cat's severe skin condition.

The device effectively and safely increased hair growth in people with Androgenetic Alopecia.

Non-biologic immunosuppressive drugs are crucial for treating autoimmune and chronic inflammatory skin diseases.

Using adipose-derived stem cell media with minoxidil may help regrow hair in men with hair loss.

Sumatriptan injections, high-flow oxygen, and verapamil effectively treat cluster headaches.

Female pattern hair loss is caused by multiple factors and while treatments like topical minoxidil, hormone therapy, and low-level light therapy can help, none can fully cure it.

A woman with severe hair loss was successfully treated with the drug adalimumab.

The document discusses male and female pattern hair loss, its diagnosis methods, FDA-approved treatments like finasteride and minoxidil, their side effects, and the role of lifestyle changes.

The document concludes that understanding and managing hair loss in cancer patients is important, and more research is needed for better treatments.

Dutasteride is more effective than finasteride for long-term hair growth in men with androgenic alopecia.

Topical treatments like minoxidil and corticosteroids are effective for hair loss, with JAK inhibitors promising for alopecia areata.

Human dental pulp stem cell-conditioned medium, especially from hypoxic conditions, may help treat chemotherapy-induced hair loss and does not increase cancer risk.

Both minoxidil-spironolactone and minoxidil-finasteride treatments work for hair loss, but minoxidil-spironolactone is slightly more effective, especially in women.

No single ideal JAK inhibitor for alopecia areata has been determined; JAK3 inhibitors may be promising with fewer side effects.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Targeted anticancer therapies can cause severe side effects similar to traditional chemotherapy, but with different types.

Gender-affirming care for youth remained essential during the COVID-19 pandemic, with telemedicine playing a key role.

Dutasteride and finasteride have similar risk for osteoporosis and fractures in older men.

JAK inhibitors help with skin conditions but need more research on dosing and safety.

Finasteride reverses early hair loss and promotes growth.

No definitive link between finasteride and male breast cancer, but further research is needed.

Dermatologists are crucial for managing skin side effects in metastatic melanoma patients using vemurafenib and ipilimumab.